After hearing weeks of testimony, a jury said bus manufacturer, Motor Coach Industries, must pay nearly $19 million to the family of a well-known Las Vegas doctor.
Category: News
Syngenta Agrees to Pay More Than $1.5 Billion in Corn Accord
Syngenta AG agreed to pay more than $1.4 billion to U.S. farmers who complained that the marketing of the company’s genetically modified corn seeds shut them out of the Chinese market, according to people familiar with the deal.
Universal Entertainment Secure $2.632 Billion Settlement with Wynn Resorts
Wynn Resorts agreed to pay $2.632 billion to Universal Entertainment to resolve claims related to Wynn Resorts' forced redemption of 24.5 million shares of Wynn Resorts common stock held by Aruze.
Specific Performance Obtained for Buyer of the Mt. Charleston Lodge
A judge compels the owners of the Mt. Charleston Lodge to honor their contracts to sell the property and business.
Health Plan of Nevada must pay $500 million in hepatitis C case
$524 Million jury verdict against Health Plan of Nevada and Sierra Health Services for patients who contracted Hepatitis C at Endoscopy Center.
Settlements reached in 41 hepatitis C lawsuits
Settlement of cases includes contested $522 million jury verdict won by Henderson school principal
$182.6M Verdict in Sacks Propofol Hepatitis Case
A jury said Teva Pharmaceutical Industries Ltd. unit and two other drugmakers must pay $162.5 million in punitive damages for selling the anesthetic Propofol in a way that led three colonoscopy patients to develop Hepatitis C.
Defective-Product Verdicts Against Companies Increase
Cybex International Inc., a fitness equipment maker, lost a $66 million jury verdict in New York last month.
Real Estate Broker Recovers $1.5M Commission
Resort Properties v. Cherry Investment involved a claim by real estate broker David Atwell's sole proprietorship, Resort Properties, for a commission from the buyer of a Las Vegas resort hotel.
Jury awards Henderson couple a record $500 million award
Plaintiff attorney Will Kemp, arguing the failure to warn case, reviewed five different reasons why Teva and Baxter allegedly provided inadequate warnings.
- 1
- 2